TIDMACPH 
 

This announcement contains inside information for the purposes of Article 7 of the Market Abuse Regulation (EU) No 596/2014.

Cambridge, UK and Indianapolis, US -- 29 April 2022, 23:00 CEST: Acacia Pharma Group plc ("Acacia Pharma", the "Group" or the "Company") (EURONEXT: ACPH), a hospital pharmaceutical company focused on the development and commercialization of new products aimed at improving the care of patients undergoing significant treatments such as surgery, other invasive procedures or cancer chemotherapy, announces the publication of its Annual Report and Financial Statements for the Year ended 31 December 2021.

The Annual Report is attached below and also available on https://www.globenewswire.com/Tracker?data=unUxIJxP3Ho3jmNAHo0ioWOzcEgFHq1Z6okOQWElMbQ6fUiLVULHZwDDCORHEOfpXkl-Q3Y_Ed-4BbmTzjNRprk0FgJppkVo_ylWKSndiPM= www.acaciapharma.com in the Investors/Financial Reports and Presentations section.

Contacts

 
Acacia Pharma Group plc                          International Media 
 Mike Bolinder, CEO                               Frazer Hall, Mark Swallow, David 
 +44 1223 919760 / +1 317 505 1280                Dible 
 mailto:IR@acaciapharma.com IR@acaciapharma.com   MEDiSTRAVA Consulting 
                                                  +44 20 3928 6900 
                                                  mailto:acaciapharma@medistrava.com 
                                                  acaciapharma@medistrava.com 
-----------------------------------------------  ------------------------------------ 
US Investors                                     Media in Belgium and the Netherlands 
 LifeSci Advisors                                 Chris Van Raemdonck 
 Irina Koffler                                    +32 499 58 55 31 
 +1 917-734-7387                                  mailto:chrisvanraemdonck@telenet.be 
 mailto:ikoffler@lifesciadvisors.com              chrisvanraemdonck@telenet.be 
 ikoffler@lifesciadvisors.com 
-----------------------------------------------  ------------------------------------ 
 

Attachment

   -- Acacia Pharma Annual Report 2021 
      https://ml-eu.globenewswire.com/Resource/Download/5cb8d7f5-83d3-49a4-8f52-02a8da4cb3a7 
 
 
 

(END) Dow Jones Newswires

April 29, 2022 17:02 ET (21:02 GMT)

Copyright (c) 2022 Dow Jones & Company, Inc.
Acacia Pharma (LSE:0PNT)
Historical Stock Chart
From Jun 2022 to Jul 2022 Click Here for more Acacia Pharma Charts.
Acacia Pharma (LSE:0PNT)
Historical Stock Chart
From Jul 2021 to Jul 2022 Click Here for more Acacia Pharma Charts.